搜尋結果
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters· 18 分鐘前, opens new tab multiple myeloma drug Blenrep nearly halved the risk of disease progression or ...
, opens new tab multiple myeloma drug Blenrep nearly halved the risk of disease progression or ...